TJPC(SH:600488) 智通财经网·2025-11-11 07:44Core Viewpoint - The company, Tianyao Pharmaceutical (600488.SH), announced that its subsidiary, Hubei Tianyao Pharmaceutical Co., Ltd., has received the drug registration certificate for Metoclopramide Hydrochloride Injection from the National Medical Products Administration [1] Group 1: Product Information - Metoclopramide Hydrochloride Injection is an antiemetic drug primarily used for nausea and vomiting caused by chemotherapy, radiotherapy, surgery, and other medical conditions [1] - The drug is also indicated for symptomatic treatment of nausea and vomiting associated with acute gastroenteritis, biliary and pancreatic disorders, and uremia [1] - Additionally, it aids in facilitating duodenal intubation and reduces nausea and vomiting during gastrointestinal barium X-ray examinations [1]